Publications by authors named "Stan Neil Finkelstein"
Am J Epidemiol
February 2025
Article Synopsis
- There is growing interest in the additional benefits of metformin, beyond its primary use for managing type 2 diabetes, including potential protective effects against cardiovascular issues, cognitive decline, and cancer.
- This study compared cancer risk in patients using metformin versus those using sulfonylureas, using a large dataset from the UK, to investigate if metformin offers any significant protective effect against cancer over a 6-year period.
- The results indicated that metformin did not significantly reduce cancer risk compared to sulfonylureas, and the analysis faced challenges including the disparity of data overlap and the issue of pre-cancer deaths affecting the outcomes.
